How much dividend does Sesen Bio pay?
Over the past 12 months, Sesen Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sesen Bio is expected to pay a dividend of 0 USD.
Sesen Bio Dividend 2024
Sesen Bio Dividend
0 USD
Sesen Bio Dividend yield
Ticker
SESN
ISIN
US8177631053
WKN
A2JL47
How much dividend does Sesen Bio 2024 pay?
According to the latest status from August 2024, Sesen Bio paid a total of 0 USD per share in dividends within the last 12 months. With the current Sesen Bio price of 6.53 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical Sesen Bio Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the Sesen Bio Dividend Safe?
Sesen Bio has been increasing the dividend for 0 years.
Over the past 10 years, Sesen Bio has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding Sesen Bio's Dividend Distributions
Sesen Bio’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Sesen Bio's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Sesen Bio's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Sesen Bio’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Sesen Bio Aktienanalyse
What does Sesen Bio do?
Sesen Bio Inc. is a biotechnology company focused on developing advanced therapeutics for the treatment of cancer and other challenging diseases. The company was founded in 2010 in Cambridge, Massachusetts, and has since expanded its research and development efforts to develop a range of therapies based on its innovative technologies and approaches. The goal of Sesen Bio is to develop groundbreaking drugs and therapies that are both safe and effective, helping patients successfully fight their illness. The company's focus is on unlocking new treatment possibilities through its proprietary platforms, including its antibody-drug conjugate (ADC) technology, on which all drug candidates are based. Sesen Bio has three main divisions: cancer treatment, therapy development, and partnership program. The cancer treatment division focuses on clinical trials and product marketing. This is where the first approved drug, Vicinium, is mentioned. Vicinium is an ADC consisting of a monoclonal antibody against prostate-specific membrane antigen (PSMA). It is indicated for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The therapy development division is involved in creating drug candidates and advancing their development through clinical trials. The partnership program allows Sesen Bio to license and commercialize its technologies and platforms by partnering with other biotechnology companies and pharmaceutical companies. The company has made significant progress in the development of therapeutics in recent years. The first approved drug, Vicinium, has propelled the company forward. The company is conducting clinical trials on other drug candidates to evaluate their efficacy and safety. Additionally, the company has a pipeline of new products in various stages of development, including NG-348, a novel ADC targeting the epidermal growth factor receptor (EGFR) that can be used in the treatment of solid tumors in various organs. Sesen Bio aims to further expand its innovative technologies in the field of cancer therapy and expand its offering of groundbreaking therapeutics. The company works closely with its partners and customers to develop customized treatment solutions and ensure high patient satisfaction. With its dedicated research and development department, well-established partnerships, and ability to make groundbreaking technologies widely available, Sesen Bio is on track to become a leading company in the field of cancer therapy. Overall, Sesen Bio is an innovative biotechnology company dedicated to developing therapeutics that improve the lives of patients with cancer and other serious diseases. Through its proprietary technologies and platforms, dedicated research and development departments, and well-established partnerships, the company has established itself as a key player in the field of cancer therapy. Sesen Bio is a company with a vision and a mission that permeate everything it does, namely saving and improving lives. Sesen Bio is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sesen Bio stock can be added to a savings plan with the following providers: Trade Republic
Frequently Asked Questions about Sesen Bio stock
What is the dividend yield of Sesen Bio?
The current dividend yield of Sesen Bio is .
When does Sesen Bio pay dividends?
Sesen Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sesen Bio?
Sesen Bio paid dividends every year for the past 0 years.
What is the dividend of Sesen Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sesen Bio located?
Sesen Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sesen Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sesen Bio from 8/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/2/2024.
When did Sesen Bio pay the last dividend?
The last dividend was paid out on 8/2/2024.
What was the dividend of Sesen Bio in the year 2023?
In the year 2023, Sesen Bio distributed 0 USD as dividends.
In which currency does Sesen Bio pay out the dividend?
The dividends of Sesen Bio are distributed in USD.
Andere Kennzahlen von Sesen Bio
Our stock analysis for Sesen Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sesen Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
